JP2006519852A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519852A5
JP2006519852A5 JP2006507175A JP2006507175A JP2006519852A5 JP 2006519852 A5 JP2006519852 A5 JP 2006519852A5 JP 2006507175 A JP2006507175 A JP 2006507175A JP 2006507175 A JP2006507175 A JP 2006507175A JP 2006519852 A5 JP2006519852 A5 JP 2006519852A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
salt
carbon atoms
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519852A (ja
Filing date
Publication date
Priority claimed from US10/402,347 external-priority patent/US7022712B2/en
Application filed filed Critical
Priority claimed from PCT/US2004/007786 external-priority patent/WO2004081006A1/en
Publication of JP2006519852A publication Critical patent/JP2006519852A/ja
Publication of JP2006519852A5 publication Critical patent/JP2006519852A5/ja
Pending legal-status Critical Current

Links

JP2006507175A 2003-03-12 2004-03-12 弱塩基の塩 Pending JP2006519852A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45403503P 2003-03-12 2003-03-12
US45451403P 2003-03-13 2003-03-13
US10/402,347 US7022712B2 (en) 2002-03-26 2003-03-26 Solubilization of weak bases
PCT/US2004/007786 WO2004081006A1 (en) 2003-03-12 2004-03-12 Weak base salts

Publications (2)

Publication Number Publication Date
JP2006519852A JP2006519852A (ja) 2006-08-31
JP2006519852A5 true JP2006519852A5 (enExample) 2007-04-19

Family

ID=32995897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507175A Pending JP2006519852A (ja) 2003-03-12 2004-03-12 弱塩基の塩

Country Status (6)

Country Link
EP (1) EP1606290A1 (enExample)
JP (1) JP2006519852A (enExample)
AU (1) AU2004220053A1 (enExample)
CA (1) CA2515289A1 (enExample)
MX (1) MXPA05009564A (enExample)
WO (1) WO2004081006A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102216306B (zh) * 2008-11-19 2014-12-24 赛福伦公司 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EP2504002B1 (en) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
KR20200028498A (ko) 2010-06-24 2020-03-16 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
HUE061596T2 (hu) 2011-07-15 2023-07-28 Boehringer Ingelheim Int Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195180A (en) * 1967-05-05 1970-06-17 Du Pont Use of Alkyl 2-Benzimidazole-Carbamate Salts a Fungicides
CA962588A (en) * 1972-05-17 1975-02-11 Her Majesty In Right Of Canada As Represented By The Minister Of The Env Ironment, And Canadian Patents And Development Limited Method, apparatus, and fungicides for the treatment of trees subject to dutch elm disease and other fungus diseases
JPS5459338A (en) * 1977-10-20 1979-05-12 Takeda Chem Ind Ltd Remedy for dermatomycosis
HU199431B (en) * 1985-02-04 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing carbendazim salts, and fungicide comprising such carbendazim salt as active ingredient
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer

Similar Documents

Publication Publication Date Title
JP2006519852A5 (enExample)
JP2010509356A5 (enExample)
JP2006182786A5 (enExample)
RU2013147744A (ru) Дозированная лекарственная форма для перорального применения
JP2020507589A5 (enExample)
JP2015512413A5 (enExample)
JP2009530398A5 (enExample)
JP2004511466A5 (enExample)
JP2008509166A5 (enExample)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2004516314A5 (enExample)
JP2014515406A5 (enExample)
JP2016503797A5 (enExample)
JP2013505969A5 (enExample)
JP2002516817A5 (enExample)
JP2001526218A5 (enExample)
YU36403A (sh) Soli izotiazol-4-karboksamida kao anti-hiperproliferacioni agensi
JP2013540114A5 (enExample)
JP2004525888A5 (enExample)
JP2005526024A5 (enExample)
JP2008503533A5 (enExample)
JP2010527985A5 (enExample)
JP2005527576A5 (enExample)
JP2007505044A5 (enExample)
JP2013506004A5 (enExample)